Opioid toxicity due to CNS depressant polypharmacy: A case report
The interaction between methadone and central nervous system depressants can cause serious adverse effects, including profound sedation, respiratory depression, coma, and death. This poses a challenge in the treatment of patients with concurrent psychiatric and substance use disorders as the combine...
Saved in:
Main Authors: | Christine Lee (Author), Annabelle Wanson, MD, FRCPC (Author), Sarah Frangou, BSc, MD (Author), David Chong, BSc, MSc, BMBS (Author), Katelyn Halpape, BSP, ACPR, PharmD, BCPP (Author) |
---|---|
Format: | Book |
Published: |
American Association of Psychiatric Pharmacists,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intranasal ketamine as a treatment for psychiatric complications of long COVID: A case report
by: Baldwin Kaitlyn PharmD, et al.
Published: (2023) -
Clozapine clinical toolkit optimizes inpatient clozapine monitoring
by: Brooke Gessner, PharmD, ACPR, et al.
Published: (2024) -
Concurrent opioid and alcohol withdrawal management
by: Michelle Colvard, PharmD, BCPP
Published: (2023) -
The use of concurrent long-acting injectable antipsychotic therapy with paliperidone palmitate and aripiprazole monohydrate in a patient with schizophrenia
by: Christopher Evernden, BSc, BScPharm, ACPR, et al.
Published: (2021) -
Characterization of inpatient care for patients admitted to a psychiatric hospital with a home opioid prescription
by: Kei Takamura, PharmD, BCPS, BCPP, et al.
Published: (2023)